Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Aurobindo Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 437.40 6.20  | 1.44% -43.84% 9.91 25,497.12
NSE Price: Nov 20, 11:24 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 20, 11:24 437.40 6.20 1.44% 432.00 431.20 1,256,518 432.00 - 438.90
BSE Nov 20, 11:35 438.55 7.40 1.72% 430.00 431.15 74,453 430.00 - 439.40
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 3,829,236 P/B: 1.68 NSE Code: AUROPHARMA
52-Week Range: R 389.35 - 838.00 Dividend Yield: 0.57% BSE Code: 524804
TTM EPS: R 43.92 Book Value: R 259.30 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Lupin (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 37 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Aurobindo Pharma -41.02 -9.54 -28.52 -45.66 -15.77 -5.15 18.80
S&P BSE Mid Cap -3.94 2.84 9.71 -1.46 7.09 7.75 8.77
S&P BSE Healthcare -5.15 4.53 5.27 -8.67 -4.59 -2.25 11.02
Company's return has been calculated on basis of BSE's price.
As on Nov 19, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 18.83 12.35 19.29
Net Profit -2.40 5.31 15.10
EPS -2.41 5.26 14.94
Book Value 18.92 23.95 29.81
Average
Operating Margin 20.99 22.78 22.97
Net Margin 11.98 13.96 13.83
Return on Networth 18.47 23.01 27.36
Return on Investment 17.97 21.87 24.03
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 2.86 17.87 5.82
Operating Profit -0.12 14.65 6.52
Net Profit 1.35 4.62 9.17
EPS 0.63 4.64 9.31
TTM
Revenue 4.09 24.27 10.44
Operating Profit 3.36 24.74 13.87
Net Profit 1.11 17.20 8.64
EPS 1.11 17.46 8.82
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Aurobindo Pharma 25,497.12 21,606.94 2,565.81 11.80 18.47 1.68 9.91
Lupin 34,095.46 17,689.22 318.63 1.77 4.55 2.50 108.66
Piramal Enterprises 35,195.84 14,278.56 1,708.87 11.71 4.28 1.32 17.03
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 16, 2019 Sampath Reddy Endhunuri  Sell Market 2,278 636.60 14.50
Aug 29, 2019 Nagaraju Ravula  Sell Market 2,626 591.10 15.52
Aug 13, 2019 Ravoori Lakshmi Narasimhaswamy  Sell Market 2,560 602.80 15.43
Jun 18, 2019 Rama Srinivas K  Sell Market 2,500 622.25 15.56
Jun 12, 2019 Sreenivasa Reddy Bhumireddy  Sell Market 2,382 641.55 15.28
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
HDFC Mutual Fund 7.031 6.780 6.070 5.985 6.100
Nippon India Mutual Fund 1.206 1.327 1.581 1.876 1.996
SBI Mutual Fund 0.981 1.592 1.665 1.558 1.356
Aditya Birla Sun Life Mutual Fund 0.714 0.752 0.838 0.869 1.363
IDFC Mutual Fund 0.564 0.526 0.764 0.667 0.536
ICICI Prudential Mutual Fund 0.376 0.434 0.461 0.517 0.553
UTI Mutual Fund 0.311 0.271 0.278 0.406 0.443
DSP Mutual Fund 0.267 0.172 0.384 0.325 0.264
Mirae Asset Mutual Fund 0.252 0.247 0.279 0.256 0.228
Kotak Mahindra Mutual Fund 0.236 0.161 0.225 0.469 0.584
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Aurobindo Pharma Ltd.

Address: Plot No. 2, Maitrivihar, Ameerpet, Hyderabad, Telangana - 500038 | Phone: +91-040-66725000 | Fax: +91-040-23746833 / 23741080

Email: [email protected]

Website: www.aurobindo.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
3.39
Piotroski F-Score
3
Modified C-Score
2
5-Years Price to Earnings
9.82
5-Years Price to Book
1.66
Earnings Yield
EBIT / Enterprise value
12.03%
PEG
Price / Earnings to growth ratio
1.15
Related Stocks
  Current Price   Chng %
Abbott India R12,822.75 +0.29%
Alkem Laboratories R2,078.60 -1.82%
Bayer CropScience R3,733.05 +0.64%
Biocon R258.50 -0.02%
Cadila Healthcare R245.45 +0.72%
Glaxosmithkline Pharma R1,647.90 +0.49%
Lupin R753.40 +0.76%
Pfizer R4,079.75 +0.64%
Piramal Enterprises R1,788.40 +1.54%
Torrent Pharmaceuticals R1,762.70 +0.21%
As on Nov 20, 11:24